Impact of heart failure and left ventricular systolic dysfunction on quality of life: A cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population

European Heart Journal

Volumn 23, Issue 23, 2002, Pages 1867-1876

  Hobbs, F D R ^a   Kenkre, J E ^a   Roalfe, A K ^a   Davis, R C ^a   Hare, R ^a   Davies, M K ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b SELLY OAK HOSPITAL   (United Kingdom)

Author keywords

Heart failure; LVSD; Quality of life

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ARTICLE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; HEALTH CARE COST; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HUMAN; MAJOR CLINICAL STUDY; PHYSICAL DISEASE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; TREATMENT OUTCOME;

ACTIVITIES OF DAILY LIVING; AGED; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0036893664     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2002.3255     Document Type: Article

References (36)

1. Davies MK, Hobbs FDR, Davis RC et al. Prevalence of left ventricular systolic dysfunction and heart failure in the general population: Main findings from the ECHOES (Echocardiographic Heart of England Screening) Study. Lancet 2001; 358: 439-45.
2. Bonneaux L, Barendregt JJ, Meeter K, Bonsel GJ, van der Maas PJ. Estimating clinical morbidity due to ischemic heart disease and congestive heart failure: The future rise of heart failure. Am J Pub Health 1994; 84: 20-8.
3. Hobbs FDR, Davis RC, McLeod S et al. Prevalence of heart failure in 'high risk' groups. J Am Coll Cardiol 1998; 31 (S5): 85C.
4. Ho KKL, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after onset of congestive heart failure in Framingham Heart Study subjects. Circulation 1993; 88: 107-15.
5. Calkins DR, Rubenstein LV, Cleary PD et al. Failure of physicians to recognize functional disability in ambulatory patients. Ann Int Med 1991; 114: 451-4.
6. Garg R, Yusuf S, for the Collaborative Group on ACE Inhibitor Trials. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA 1995; 273: 1450-6.
7. Lechat P, Packer M, Chalon S, Cucherat M, Arab T, Boissel JP. Beta-blockers in heart failure: Meta-analysis of randomized trials. Circulation 1998; 98: 1184-91.
8. Rogers WJ, Johnstone DE, Yusuf S et al. Quality of life among 5,025 patients with left ventricular dysfunction randomized between placebo and enalapril: The Studies of Left Ventricular Dysfunction. J Am Coll Cardiol 1994; 23: 393-400.
9. SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325: 293-302.
10. SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992; 327: 685-91.
11. Jenkinson C, Jenkinson D, Shepperd S, Layte R, Peterson S. Evaluation of treatment for congestive heart failure in patients aged 60 years and older using generic measures of health status (SF-36 and COOP charts). Age Ageing 1997; 26: 7-13.
12. Remes J, Miettinen H, Reunanen A, Pyörälä K. Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J 1991; 12: 315-21.
13. Willenheimer R, Erhardt L, Cline C, Rydberg E, Israelsson B. Exercise training in heart failure improves quality of life and exercise capacity. Eur Heart J 1998; 19: 774-81.
14. Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney RM. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 1995; 333: 1190-5.
15. Doba N, Tomiyama H, Nakayama T. Drugs, heart failure and quality of life: What are we achieving? What should we be trying to achieve? Drugs Aging 1999; 14: 153-63.
16. Krumholz HM, Baker DW, Ashton CM et al. Evaluating quality of care for patients with heart failure. Circulation 2000; 101: 122-40.
17. Rector TS, Tschumperlin LK, Kubo SH et al. Using the living with heart failure questionnaire to ascertain patients' perspectives on improvement in quality of life versus risk of druginduced death. J Cardiac Failure 1995; 1: 201-6.
18. Konstam V, Salem D, Pouleur H et al. for the SOLVD investigators. Baseline quality of life as a predictor of mortality and hospitalization in 5025 patients with congestive heart failure. Am J Cardiol 1996; 78: 890-5.
19. Stewart AL, Greenfield S, Hays RD et al. Functional status and well-being of patients with chronic conditions. Results from the medical outcomes study. JAMA 1989; 262: 907-13.
20. Cline CM, Willenheimer RB, Erhardt LR, Wiklund I, Israelsonn BY. Health related quality of life in elderly patients with heart failure. Scand Cardiol J 1999; 33: 278-85.
21. Havranek EP, Ware MG, Lowes BD. Prevalence of depression in congestive heart failure. Am J Cardiol 1999; 84: 348-50.
22. Murberg TA, Bru E, Svebak S, Tveteras R, Aarsland T. Depressed mood and subjective health symptoms as predictors of mortality in patients with congestive heart failure: A two-years follow-up study. Int J Psych Med 1999; 29: 311-26.
23. The Task Force on Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis of heart failure. Eur Heart J 1995; 16: 741-51.
24. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF36). I. Conceptual framework and item selection. Med Care 1992; 30: 473-83.
25. Donovan JL, Frankel SJ, Eyles JD. Assessing the need for health status measures. J Epidem Community Health 1993; 47: 158-62.
26. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951; 16: 297-334.
27. Hunt SM, McEwen J, McKenna SP. Measuring Health Status. Beckenham: Croom Helm, 1986.
28. Ware JE, Kosinski M, Keller SD. SF-36 Physical and Mental Health Summary Scales: A User's Manual. Boston, MA: The Health Institute, 1994.
29. Garratt AM, Ruta DA, Abdalla MI, Buckingham JK, Russell IT. The SF36 health survey questionnaire: An outcome measure suitable for routine use in the NHS? Br Med J 1993; 306: 1440-4.
30. SAS Institute Inc. SAS/STAT® User's Guide, Version 6, 4th Edition, Cary, NC: SAS Institute Inc., 1989.
31. Brown N, Melville M, Gray D. Quality of life four years after acute myocardial infarction: Short form 36 scores compared with a normal population. Heart 1999; 81: 352-8.
32. Rogers WJ, Johnstone DE, Yusuf S et al. Quality of life among 5025 patients with left ventricular dysfunction randomized between placebo and enalapril: The Studies of Left Ventricular Dysfunction. J Am Coll Cardiol 1994; 23: 393-400.
33. Jenkinson C, Jenkinson D, Shepperd S, Layte R, Peterson S. Evaluation of treatment for congestive heart failure in patients aged 60 years and older using generic measures of health status (SF-36 and COOP charts). Age Ageing 1997; 26: 7-13.
34. Remes J, Miettinen H, Reunanen A, Pyörälä K. Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J 1991; 12: 315-21.
35. Cowley AJ, Skene AM. Treatment of severe heart failure: Quantity or quality of life? A trial of enoximone. Enoximone Investigators. Br Heart J 1994; 72: 226-30.
36. Cohen J. Statistical Power Analysis for the Behavioural Sciences, 2nd ed. New Jersey: Lawrence Erlbaum Associates, 1988.